Objective To investigate the risk of incident cognitive disorders in patients with primary Sjögren’s disease (pSjD) using nationwide Korean National Health Insurance Service data. Methods This ...
Blinatumomab, a CD19×CD3 bispecific T-cell engager approved for B-cell acute lymphoblastic leukaemia,8 induces rapid and profound B-cell depletion and has shown immunomodulatory effects in selected ...
Background Patients with systemic lupus erythematosus (SLE) carry a substantial comorbidity load associated with worse prognosis, yet most evidence pertains to long-standing disease. How comorbidities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results